Burning Rock Biotech (BNR) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$595.6 million.
- Burning Rock Biotech's Retained Earnings fell 147.75% to -$595.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$595.6 million, marking a year-over-year decrease of 147.75%. This contributed to the annual value of -$575.4 million for FY2024, which is 601.72% down from last year.
- Burning Rock Biotech's Retained Earnings amounted to -$595.6 million in Q3 2025, which was down 147.75% from -$589.6 million recorded in Q2 2025.
- Burning Rock Biotech's Retained Earnings' 5-year high stood at -$244.7 million during Q1 2021, with a 5-year trough of -$595.6 million in Q3 2025.
- Over the past 5 years, Burning Rock Biotech's median Retained Earnings value was -$492.9 million (recorded in 2023), while the average stood at -$470.3 million.
- In the last 5 years, Burning Rock Biotech's Retained Earnings plummeted by 7428.96% in 2021 and then tumbled by 147.75% in 2025.
- Over the past 5 years, Burning Rock Biotech's Retained Earnings (Quarter) stood at -$349.7 million in 2021, then crashed by 32.66% to -$463.9 million in 2022, then fell by 16.99% to -$542.8 million in 2023, then fell by 6.02% to -$575.4 million in 2024, then fell by 3.51% to -$595.6 million in 2025.
- Its Retained Earnings was -$595.6 million in Q3 2025, compared to -$589.6 million in Q2 2025 and -$580.7 million in Q1 2025.